Figure 2.
Figure 2. Probability of event-free survival (EFS) for patients who were randomized to receive either mercaptopurine or thioguanine during maintenance treatment according to protocol COALL-92.

Probability of event-free survival (EFS) for patients who were randomized to receive either mercaptopurine or thioguanine during maintenance treatment according to protocol COALL-92.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal